- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07586423
Effect of Virtual Reality on Pain, Anxiety and Vital Signs During Diabetic Foot Care
7. maj 2026 opdateret af: Yasemin Özkul, Malatya Turgut Ozal University
The Effect of Virtual Reality Intervention on Pain Level, State Anxiety, and Vital Signs During Foot Care in Individuals With Diabetic Foot Ulcers
This study aims to determine the effects of a virtual reality (VR) intervention on pain level, state anxiety, and vital signs during foot care in individuals with diabetic foot ulcers.
The study was designed as a randomized controlled trial and includes 64 individuals with diabetes (intervention=32, control=32).
The intervention group will receive VR during diabetic foot care, while the control group will receive standard care.
Data will be collected at pre-test and post-test using the Demographic Information Form, Vital Signs Form, State-Trait Anxiety Inventory (STAI), and Visual Analog Scale (VAS) for pain.
Data analysis will be performed using SPSS 22.0.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
64
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Malatya
-
Malatya, Malatya, Tyrkiet (Türkiye), 4400
- Malatya Turgut Özal University Training and Research Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Age 18 years and older Diagnosis of Type 2 Diabetes Mellitus Diabetic foot ulcer classified as Wagner stage 3 or 4 No mental or physical condition that would interfere with communication or participation No visual or hearing impairment Ability to understand and speak Turkish Willingness to participate in the study
Exclusion Criteria:
- Presence of chronic wounds other than diabetic foot ulcer (e.g., arterial or venous ulcers) Age under 18 years
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Intervention Group (VR Group)
Participants received virtual reality (VR) intervention during diabetic foot care procedures in addition to standard care.
VR was used as a non-pharmacological distraction method during the procedure.
|
Participants in the intervention group received virtual reality (VR) exposure during diabetic foot care procedures.
A virtual reality headset was used as a non-pharmacological distraction method to reduce pain and anxiety.
The VR intervention was applied during the procedure in addition to standard diabetic foot care.
Vital signs such as blood pressure, pulse rate, respiratory rate, oxygen saturation, and body temperature were monitored before and after the procedure to evaluate physiological responses.
Andre navne:
Participants in the control group received standard diabetic foot care according to institutional protocols, without any virtual reality intervention.
Vital signs including blood pressure, pulse rate, respiratory rate, oxygen saturation, and body temperature were monitored before and after the procedure.
|
|
Aktiv komparator: Control Group
Participants received standard diabetic foot care without virtual reality intervention.
|
Participants in the control group received standard diabetic foot care according to institutional protocols, without any virtual reality intervention.
Vital signs including blood pressure, pulse rate, respiratory rate, oxygen saturation, and body temperature were monitored before and after the procedure.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Pain Level
Tidsramme: Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Pain intensity measured using the Visual Analog Scale (VAS), a 10 cm horizontal line anchored at 0 (no pain) and 10 (worst imaginable pain).
Higher scores indicate greater pain.
Change is calculated as post-test score minus pre-test score.
|
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in State Anxiety
Tidsramme: Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
State anxiety measured using the State subscale of the State-Trait Anxiety Inventory (STAI-I), a validated 20-item self-report scale scored 20-80.
Higher scores indicate greater anxiety.
Change is calculated as post-test score minus pre-test score.
|
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Body Temperature
Tidsramme: Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Body temperature (°C) measured using a non-contact infrared thermometer (Life Net Medical JA-11C).
Change is calculated as post-test value minus pre-test value.
|
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
|
Change in Oxygen Saturation (SpO₂)
Tidsramme: Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Peripheral oxygen saturation (SpO₂, %) measured using a fingertip pulse oximeter (Life Net Medical PFX033).
Change is calculated as post-test value minus pre-test value.
|
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
|
Change in Pulse Rate
Tidsramme: Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Pulse rate (beats per minute) measured using a fingertip pulse oximeter (Life Net Medical PFX033).
Change is calculated as post-test value minus pre-test value.
|
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
|
Change in Respiratory Rate
Tidsramme: Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Respiratory rate (breaths per minute) assessed by direct observation and counting by the researcher.
Change is calculated as post-test value minus pre-test value.
|
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
|
Change in Systolic Blood Pressure
Tidsramme: Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Systolic blood pressure (mmHg) measured using an upper-arm automated sphygmomanometer (Omron M3 Comfort HEM-7155-E) after the participant had been seated and resting for at least 5 minutes.
Change is calculated as post-test value minus pre-test value.
|
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
|
Change in Diastolic Blood Pressure
Tidsramme: Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Diastolic blood pressure (mmHg) measured using an upper-arm automated sphygmomanometer (Omron M3 Comfort HEM-7155-E) after the participant had been seated and resting for at least 5 minutes.
Change is calculated as post-test value minus pre-test value.
|
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
9. december 2024
Primær færdiggørelse (Faktiske)
15. juni 2025
Studieafslutning (Faktiske)
15. juni 2025
Datoer for studieregistrering
Først indsendt
30. april 2026
Først indsendt, der opfyldte QC-kriterier
7. maj 2026
Først opslået (Faktiske)
14. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
14. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
7. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neurologiske manifestationer
- Sygdomme i det endokrine system
- Karsygdomme
- Hjerte-kar-sygdomme
- Psykiske lidelser
- Diabetes mellitus
- Diabetiske angiopatier
- Diabetes komplikationer
- Hudsygdomme
- Hudsår
- Bensår
- Diabetiske neuropatier
- Fodsår
- Patologiske tilstande, tegn og symptomer
- Hud- og bindevævssygdomme
- Tegn og symptomer
- Smerte
- Angstlidelser
- Diabetisk fod
Andre undersøgelses-id-numre
- E-30785963-020-266758
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
Individual participant data (IPD) will not be shared due to patient privacy and confidentiality concerns.
The data are collected within a single institutional clinical study for academic thesis purposes and are not planned for public data sharing.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Diabetisk fodsår
-
Assiut UniversityUkendtom Vitreomacular Interface Abnormalities in Diabetic Retinopathy
Kliniske forsøg med VR
-
Prof. Dominique de Quervain, MDRekrutteringLangsom vejrtrækningSchweiz
-
Alexandra HospitalIkke rekrutterer endnuNyresvigt, kronisk
-
University of LincolnRekrutteringVelvære | Palliativ pleje | Virtual realityDet Forenede Kongerige
-
Universitas AirlanggaTokyo University; Chiba UniversityTilmelding efter invitation
-
Shanghai Mental Health CenterNanjing XR-Oasis Technology Co., Ltd.RekrutteringManiodepressiv | Interventionsundersøgelse | VRKina
-
October 6 UniversityAktiv, ikke rekrutterendeIkke-specifik kronisk lænderygsmerterJordan
-
The Hospital for Sick ChildrenStanford UniversityAfsluttet
-
Indiana UniversityIndiana University HealthRekrutteringPost-intensiv afdelings syndrom | Delirium på intensivafdelingen | Intensiv pleje erhvervet kognitiv svækkelse | Virtual reality kognitiv træningForenede Stater
-
University of Maryland, BaltimoreRekrutteringSmerte | Virtual reality | Temporomandibulær lidelse | PlaceboForenede Stater
-
Cornell UniversityAfsluttetSmertetærskelForenede Stater